1064
M. Dabiri, Z. N. Tisseh, and A. Bazgir
Vol 47
Scheme 2
Table 2
Synthesis of dibenzo[a,i]xanthene-diones 7.
Product 7
Ar
Time (h)
Yield (%)
a
b
c
d
e
f
g
h
I
C6H5
16
15
16
14
14
16
16
15
16
82
90
86
82
84
83
87
81
80
4-ClAC6H4
4-BrAC6H4
4-FAC6H4
4-NO2AC6H4
4-MeAC6H4
2-ClAC6H4
3-NO2AC6H4
3-BrAC6H4
300.13 and 75.47 MHz, respectively. Elemental analyses were
performed using a Heracus CHN-O-Rapid analyzer.
8.07 (1H, m, H-Ar). 13C NMR (75 MHz, DMSO-d6): dc 26.9,
28.9, 32.4, 32.7, 40.1, 113.6, 124.2, 126.2, 126.5, 127.2, 128.7,
128.8, 129.0, 130.9, 131.4, 134.6, 135.0, 143.2, 149.5, 163.4,
177.5, 183.2, 196.3. MS (m/z) 384 (Mþ). Anal. Calcd for
C25H20O4: C, 78.11; H, 5.24;%. Found: C, 78.21; H, 5.29%.
12-(4-Chlorophenyl)-3,3-dimethyl-3,4-dihydro-1H-ben-
zo[b]xanthene-1,6,11(2H,12H)-trione (7b). Yellow powder
(90%); mp: 282–284ꢀC. IR (KBr) (mmax/cmꢁ1): 2932, 1663,
Typical procedure for preparation of 14-phenyl-8H-
dibenzo[a,i]xanthene-8,13(14H)-dione (4a). A mixture of
benzaldehyde (0.11 g, 1 mmol), 2-naphtol (0.140 g, 1 mmol),
2-hydroxynaphthalene-1,4-dione (0.17 g, 1 mmol), p-TSA (0.1
g) was refluxed in water (5 mL) for 10 h (TLC). At the end of
the reaction, the precipitate formed was collected by filtration
and washed with ethanol to afford the pure product 4a. Orange
powder (88%); m.p. 294–297ꢀC; IR (KBr) (mmax/cmꢁ1): 3054,
1
1
1618, 1594. H NMR (300 MHz, DMSO-d6): dH 0.94 (3H, s,
1703, 1656; H NMR (DMSO-d6): dH 5.09 (1H, s, CH), 7.16–
8.08 (15H, m, H-Ar). MS (m/z) 388 (Mþ). Anal. Calcd (%) for
C27H16O3: C, 83.49; H, 4.15. Found C, 83.55; H, 4.10.
Selected Characterization Data.
CH3), 1.06 (3H, s, CH3), 2.15 and 2.31 (2H, AB system, J ¼
16.2 Hz, CH2), 2.67 (2H, s, CH2), 4.89 (1H, s, CH), 7.28–7.37
(4H, m, H-Ar), 7.83–7.90 (3H, m, H-Ar), 8.03–8.06 (1H, m,
H-Ar). 13C NMR (75 MHz, DMSO-d6): dc 26.9, 29.0, 32.5,
33.7, 33.5, 50.5, 113.7, 124.2, 126.2, 126.5, 127.2, 128.6,
129.1, 130.9, 131.4, 134.6, 135.0, 143.2, 149.5, 163.4, 183.3,
196.4. MS (m/z) 418 (Mþ). Anal. Calcd for C25H19ClO4: C,
71.69; H, 4.57%. Found: C, 71.78; H, 4.50%.
14-(4-Chlorophenyl)-8H-dibenzo[a,i]xanthene-8,13(14H)-
dione(4b). Yellow powder (83%); m.p. 281–284ꢀC; IR (KBr)
1
(mmax/cmꢁ1): 3044, 1699, 1663; H NMR (DMSO-d6): dH 5.77
(1H, s, CH), 7.24 (2H, d, J ¼ 7.4 Hz, H-Ar), 7.39 (2H, d, J ¼
7.4 Hz, H-Ar), 7.46–7.51 (2H, m, H-Ar). 7.67–7.74 (2H, m,
H-Ar). 7.86 (1H, d, J¼7.1 Hz, H-Ar), 7.90–8.02 (4H, m, H-
Ar), 8.20 (1H, d, J¼7.1 Hz, H-Ar). MS (m/z, %) 422 (Mþ).
Anal. Calcd (%) for C27H15ClO3: C, 76.69; H, 3.58. Found C,
76.61; H, 3.52.
12-(4-Bromophenyl)-3,3-dimethyl-3,4-dihydro-1H-ben-
zo[b]xanthene-1,6,11(2H,12H)-trione (7c). Yellow powder
(86%); mp: 268–270ꢀC. IR (KBr) (mmax/cmꢁ1): 2957, 1660,
1
1616, 1579. H NMR (300 MHz, DMSO-d6): dH 0.94 (3H, s,
CH3), 1.07 (3H, s, CH3), 2.15 and 2.31 (2H, AB system, J ¼
15.9 Hz, CH2), 2.67 (2H, s, CH2), 4.88 (1H, s, CH), 7.10–7.12
(2H, d, J ¼ 8.4 Hz, H-Ar), 7.42–7.45 (2H, m, H-Ar), 7.83–
7.90 (3H, m, H-Ar), 8.03–8.06 (1H, m, H-Ar). 13C NMR (75
MHz, DMSO-d6): dc 27.3, 29.0, 32.4, 33.7, 40.7, 50.5, 113.3,
123.8, 123.9, 126.6, 126.8, 129.7, 130.4, 131.4, 134.1, 134.7,
146.9, 149.3, 149.6, 163.4, 177.5, 196.0. MS (m/z) 464 (Mþ),
462 (Mþ). Anal. Calcd for C25H19BrO4: C, 64.81; H, 4.13%.
Found: C, 64.73; H, 4.20%.
14-(4-Bromophenyl)-8H-dibenzo[a,i]xanthene-8,13(14H)-
dione (4c). Yellow powder (89%); m.p. 294–298ꢀC; IR (KBr)
1
(mmax/cmꢁ1): 3075, 1704, 1663; H NMR (DMSO-d6): dH 5.89
(1H, s, CH), 7.27–7.34 (4H, m, H-Ar), 7.45 (2H, t, J ¼ 6.8
Hz, H-Ar). 7.50–7.62 (2H, m, H-Ar), 7.79 (1H, t, J ¼ 7.6 Hz,
H-Ar). 7.85–7.92 (3H, m, H-Ar), 8.11–8.18 (2H, m, H-Ar).
MS (m/z, %) 468 (Mþ þ 2), 466 (Mþ). Anal. Calcd (%) for
C27H15BrO3: C, 69.39; H, 3.24. Found C, 69.30; H, 3.33.
Due to very low solubility of the product 4a–c, we cannot
report the 13C NMR data for this product.
12-phenyl-3,4-dihydro-1H-benzo[b]xanthene-1,6,11(2H,12H)-
trione (7a). Orange powder (82%); mp: 263–265ꢀC. IR (KBr)
(mmax/cmꢁ1): 2926, 1678, 1606. 1H NMR (300 MHz, DMSO-
d6): dH 0.94 (3H, s, CH3), 1.07 (3H, s, CH3), 2.15 and 2.31
(2H, AB system, J ¼ 16.2 Hz, CH2), 2.67 (2H, s, CH2), 4.88
(1H, s, CH), 7.10–7.15 (1H, m, H-Ar), 7.21–7.32 (2H, m, H-
Ar), 7.43–7.46 (2H, m, H-Ar). 7.80–7.91 (3H, m, H-Ar) 7.99–
REFERENCES AND NOTES
¨
[1] Domling, Wan, P.; Backer, B.; Diao, L.; Fischer, M.; Shi,
Y.; Yang, C. Cancer J. Chem. 1996, 74, 465.
[2] Desimoni, G.; Tacconi, G. Chem. Rev. 1975, 75, 651.
[3] Van De Water, R. W.; Pettus, T. R. R. Tetrahedron 2002, 58,
5367.
[4] (a) Rajitha, B.; Kumar, B. S.; Reddy, Y. T.; Reddy, P. N.;
Sreenivasulu, N. Tetrahedron Lett. 2005, 46, 8691; (b) Khosropour,
A. R.; Khodaei, M. M.; Moghannian, H. Synlett 2005, 955; (c) Ko, S.;
Yao, C.-F. Tetrahedron Lett. 2006, 47, 8827.
Scheme 3
[5] (a) Cimarelli, C.; Palmieri, G.; Volpini, E. Tetrahedron:
Asymmetry 2002, 13, 2417; (b) Lu, J.; Xu, X.; Wang, C.; He, J.; Hu,
´ ´ ´
Y.; Hu, H. Tetrahedron Lett 2002, 43, 8367; (c) Szatmari, I.; Lazar,
¨
L.; Fu¨lop, F. Tetrahedron Lett. 2006, 47, 3881; (d) Saidi, M. R.; Azizi,
N. Tetrahedron: Asymmetry 2003, 14, 389; (e) Khosropour, A. R.;
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet